Cellspect

About:

Cellspect is a biotechnology business that creates biomarker-sensing technology for the transition from clinical to health tech markets.

Website: https://cellspect.com

Top Investors: Mitsubishi UFJ Capital, Mizuho Capital, Development Bank of Japan, Iwagin Jigyo Souzou Capital, Aflac Global Ventures

Description:

Cellspect is a development of clinical diagnostic methods by sensing disease markers.

Total Funding Amount:

3.53B JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Morioka, Iwate, Japan

Founded Date:

2014-04-18

Contact Email:

info(AT)cellspect.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2019-11-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai